PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Infectious Diseases, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.\', \'Department of Microbiology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.\', \'Department of Virology, Toyama Institute of Health, 17-1 Nakataikoyama, Imizu-shi, Toyama, 939-0363, Japan.\', \'Department of Clinical Infectious Diseases, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan. yamamoto@med.u-toyama.ac.jp.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-021-96143-8
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 34400739
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • Delayed neutralizing antibody response in the acute phase correlates with severe progression of COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all